ID

26748

Descrizione

Study Part: Pre-dose Checklist Week 5 PK Visit (Visit 9). An open-label, up-titration study to assess the dose proportionality of ropinirole controlled release (CR) and to demonstrate the bioequivalence of ropinirole CR (1 x 8 mg) compared to the ropinirole CR (4 x 2 mg) in Parkinson's Disease patients not receiving other dopaminergic therapies. Patient Level Data: Study Listed on ClinicalStudyDataRequest.com. Sponsor: GlaxoSmithKline. Phase: phase 2. Study Recruitment Status: Completed. Generic Name: ropinirole. Trade Name: Modutab, ZIPEREVE, ZEPREVE, REPREVE, ADARTREL, REQUIP,Zygara. Study Indication: Parkinson Disease. Study ID: 101468/165. Clinical Study ID: 101468/165

Keywords

versioni (1)
  1. 23/10/17 23/10/17 -
Titolare del copyright

GlaxoSmithKline

Caricato su

23 ottobre 2017

DOI

Per favore, per richiedere un accesso.

Licenza

Creative Commons BY-NC 3.0
Commenti del modello :

Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.

Torna ai commenti del modello
Commenti del gruppo di articoli per :

Commenti dell'articolo per :

  • i più nuovi
  • i più vecchi
  • Popolare
  • i più nuovi
    • i più nuovi
    • i più vecchi
    • Popolare

Non ci sono commenti

Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.

Pre-dose Checklist Week 5 PK Visit (Visit 9) Ropinirole Parkinson Disease 101468/165

Inglese

Pre-dose Checklist Week 5 PK Visit (Visit 9)

1 moduli  
PREDOSE CHECKLIST
Descrizione

PREDOSE CHECKLIST

Alias
UMLS CUI-1
C0439565
UMLS CUI-2
C1707357
Patient Number
Descrizione

Patient Number

Tipo di dati

text

Alias
UMLS CUI [1]
C1830427
Centre Number
Descrizione

Centre Number

Tipo di dati

integer

Alias
UMLS CUI [1,1]
C0600091
UMLS CUI [1,2]
C0019994
Visit Date
Descrizione

Visit Date

Tipo di dati

date

Alias
UMLS CUI [1]
C1320303
1. Has the patient refrained from consuming alcohol for 24 hours prior to the clinic visit?
Descrizione

alcohol consumption

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0001948
2. Has the patient tried to refrain from consuming xanthine-containing beverage and foods (coffee, tea, cola beverages, cocoa, chocolate), grapefruit-containing products, quinine-containing products and food containing CYP1A2-inducing constituents (broccoli, bussels sprouts, cabbage etc.) within 24 hours of the clinic visit?
Descrizione

xanthine-containing beverage and foods

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0043314
UMLS CUI [1,2]
C0016452
3. Has the patient refrained from consuming poppy seed-containing food (e.g. poppy cake) for three days before the clinic visit?
Descrizione

poppy seed-containing food

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0453264
UMLS CUI [1,2]
C0016452
4. Has the patient maintained their normal smoking practice?
Descrizione

smoking history

Tipo di dati

text

Alias
UMLS CUI [1]
C1519384
5. Has the subject had at least 3 sequential days of dosing?
Descrizione

dosage

Tipo di dati

text

Alias
UMLS CUI [1]
C0178602
6. If the patient is already taking a drug known to substantially inhibit CYP1A2 or induce CYP1A2, has the patient remained on stable doses of the agent from 7 days prior to dosing with study medication?
Descrizione

CYP1A2 inhibitors or inducers

Tipo di dati

text

Alias
UMLS CUI [1,1]
C1827504
UMLS CUI [1,2]
C1827490
Comments:
Descrizione

Comments

Tipo di dati

text

Alias
UMLS CUI [1]
C0947611
Ritorna all'inizio della pagina

Similar models

Pre-dose Checklist Week 5 PK Visit (Visit 9)

1 moduli
Name
genere
Description | Question | Decode (Coded Value)
Tipo di dati
Alias
Item Group
PREDOSE CHECKLIST
C0439565 (UMLS CUI-1)
C1707357 (UMLS CUI-2)
Patient Number
Item
Patient Number
text
C1830427 (UMLS CUI [1])
Centre Number
Item
Centre Number
integer
C0600091 (UMLS CUI [1,1])
C0019994 (UMLS CUI [1,2])
Visit Date
Item
Visit Date
date
C1320303 (UMLS CUI [1])
alcohol consumption
Item
1. Has the patient refrained from consuming alcohol for 24 hours prior to the clinic visit?
boolean
C0001948 (UMLS CUI [1])
xanthine-containing beverage and foods
Item
2. Has the patient tried to refrain from consuming xanthine-containing beverage and foods (coffee, tea, cola beverages, cocoa, chocolate), grapefruit-containing products, quinine-containing products and food containing CYP1A2-inducing constituents (broccoli, bussels sprouts, cabbage etc.) within 24 hours of the clinic visit?
boolean
C0043314 (UMLS CUI [1,1])
C0016452 (UMLS CUI [1,2])
poppy seed-containing food
Item
3. Has the patient refrained from consuming poppy seed-containing food (e.g. poppy cake) for three days before the clinic visit?
boolean
C0453264 (UMLS CUI [1,1])
C0016452 (UMLS CUI [1,2])
Item
4. Has the patient maintained their normal smoking practice?
text
C1519384 (UMLS CUI [1])
smoking history
Code List
4. Has the patient maintained their normal smoking practice?
CL Item
Yes (Yes)
CL Item
No (No)
CL Item
N/A (N/A)
Item
5. Has the subject had at least 3 sequential days of dosing?
text
C0178602 (UMLS CUI [1])
smoking history
Code List
5. Has the subject had at least 3 sequential days of dosing?
CL Item
Yes (Yes)
CL Item
No (No)
CL Item
N/A (N/A)
Item
6. If the patient is already taking a drug known to substantially inhibit CYP1A2 or induce CYP1A2, has the patient remained on stable doses of the agent from 7 days prior to dosing with study medication?
text
C1827504 (UMLS CUI [1,1])
C1827490 (UMLS CUI [1,2])
smoking history
Code List
6. If the patient is already taking a drug known to substantially inhibit CYP1A2 or induce CYP1A2, has the patient remained on stable doses of the agent from 7 days prior to dosing with study medication?
CL Item
Yes (Yes)
CL Item
No (No)
CL Item
N/A (N/A)
Comments
Item
Comments:
text
C0947611 (UMLS CUI [1])
Ritorna all'inizio della pagina 

Aiuto

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial